中财网 中财网股票行情
荣昌生物(688331)财务分析指标    年份：
截止日期2026-03-312025-12-312025-09-302025-06-302025-03-31
营业总收入(万元)65621.44325105.11171983.30109795.3452596.86
营业收入(万元)65621.44325105.11171983.30109795.3452596.86
营业总成本(万元)69687.88319171.66227206.07154773.5677936.90
营业成本(万元)11695.6541354.0527059.3417501.918803.08
净利润(万元)32833.8076230.19-50110.77-41955.82-24215.15
归属于母公司的净利润(万元)32800.7170964.98-55070.06-44956.87-25414.45
营业利润(万元)33017.0372260.59-53726.92-44115.41-24974.65
利润总额(万元)32849.3671039.85-55070.06-44956.87-25414.45
少数股东损益(万元)----------
基本每股收益(元)0.58(元)1.29(元)-1.01(元)-0.83(元)-0.46(元)
稀释每股收益(元)0.58(元)1.29(元)-1.01(元)-0.83(元)-0.46(元)
非经常性损益(万元)-----545.63---208.52
扣除非经常性损益后净利润(万元)-3499.106767.55-54524.42-44551.75-25205.92
总资产(万元)736519.39724807.23597712.99585035.81530734.50
总负债(万元)343672.93363925.06365704.68349286.75353592.00
归属于母公司股东权益合计(万元)392846.47360882.17232008.31235749.06177142.51
股东权益合计(万元)392846.47360882.17232008.31235749.06177142.51
实收资本(股本)(万元)56447.7556371.0256360.8256360.8254433.21
资本公积(万元)696506.86692379.66692375.71696050.42628194.63
未分配利润(万元)-323995.92-360671.59-487257.18-477143.99-457601.57
经营活动产生的现金流量净额(万元)1131.805295.1921705.74-24553.93-18831.51
经营活动现金流入小计(万元)77060.84271924.14225593.59107758.3747999.99
经营活动现金流出小计(万元)75929.04266628.95203887.84132312.2966831.50
投资活动产生的现金流量净额(万元)2057.98-20564.79-27954.57-11904.98-2678.79
投资活动现金流入小计(万元)66455.34216495.91106279.4926165.4315985.10
投资活动现金流出小计(万元)64397.35237060.70134234.0638070.4118663.89
筹资活动产生的现金流量净额(万元)-8253.2655195.8337096.8788033.6117672.40
筹资活动现金流入小计(万元)19119.03284972.49211727.13197487.5553069.65
筹资活动现金流出小计(万元)27372.29229776.66174630.25109453.9435397.26
期末现金及现金等价物余额(万元)109863.08115459.85106739.01127100.0371878.30
最后修改日期2026-04-282026-03-282025-11-012025-08-222025-04-29
↑返回页顶↑

转至荣昌生物（688331）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。